Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04078321
Other study ID # Mollii
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 1, 2019
Est. completion date September 1, 2021

Study information

Verified date January 2021
Source Sormland County Council, Sweden
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The main purpose with this study is to investigate the effectiveness of a garment with integrated electrodes for multifocal transcutaneous electrical stimulation intended for treatment of spasticity in children with cerebral palsy.


Description:

The effect and use of the garment will be evaluated in single - case studies using ABAB design.


Recruitment information / eligibility

Status Completed
Enrollment 8
Est. completion date September 1, 2021
Est. primary completion date August 1, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 4 Years to 18 Years
Eligibility Inclusion Criteria: - Cerebral palsy diagnosis, with spasticity as the main symptom - Established GMFCS, levels 1-5 - MACS level, levels 1-5 - Included in the CPUP * national quality register - Person should be between 4 years and up to 18 years - Secured communication to and from person - Neing able to convey pain or discomfort. Exclusion Criteria: - No treatment received within next three months before participation with botulinum toxin treatment to reduce spasticity. - The patient may not have a shunt or other medical pump that may be affected by the electrical stimulation provided by the garment.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Mollii ®
The garment claims to have a 48 hours lasting effect of an hour of treatment. The garment should be worn for at least 1 hour every other day. All participants receive individually tailored garments and individually tailored appropriate training towards specific goals set in connection to study start. The garment is used in the home environment and the family is responsible for documentation of use in a diary. Measurements is performed following an ABAB design for four weeks. Measurement performed at 12 occasions during the four weeks are; spasticity, physical function, pain, sleep and adherence. Standardized protocols for the intervention are provided to involved physical therapists.

Locations

Country Name City State
Sweden Marina Arkkukangas Eskilstuna

Sponsors (1)

Lead Sponsor Collaborator
Sormland County Council, Sweden

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Modified Ashworth Scale Measures of spasticity at 12 Occasions using the Modified Ashworth Scale. Measures include both upper and lower limbs. Scores are rated by::
0= No increase in muscle tone
Slight increase in muscle tone, manifested by a catch and release or by minimal resistance at the end of the range of motion when the affected part(s) is moved in flexion or extension 1+= Slight increase in muscle tone, manifested by a catch, followed by minimal resistance throughout the remainder (less than half) of the ROM
More marked increase in muscle tone through most of the ROM, but affected part(s) easily moved
Considerable increase in muscle tone, passive movement difficult
Affected part(s) rigid in flexion or extension
The mesures will be perfomed three times each week for four weeks.
four weeks
Secondary Timed Up and Go (time) Measures of physical function at 12 Occasions, the mesures will be perfomed three times each week for four weeks.
Instructions:
The patient should sit on a standard armchair, placing his/her back against the chair and resting his/her arms chair's arms. Any assistive device used for walking should be nearby. Regular footwear and customary walking aids should be used. The patient should walk to a line that is 3 meters (9.8 feet) away, turn around at the line, walk back to the chair, and sit down. The test ends when the patient's buttocks touch the seat. Patients should be instructed to use a comfortable and safe walking speed. A stopwatch should be used to time the test (in seconds).
four weeks
Secondary Faces pain scale 0-5 Measures of pain recorded daily in a diary. Rating 0 indicating four weeks
Secondary Two questions of sleeling quality, three answer options provided Measures of sleep recorded daily in a diary four weeks
Secondary Adherence measured by days using the garment during the intervention The participant will report in a diary each day the garment is used and the diary also provide the possibility to add a comment. four weeks
Secondary Level of Sitting Scale (score 1-8) Measures of physical function at 12 Occasions, the mesures will be perfomed three times each week for four weeks.
The participant will be placed in sitting position. Score 1 indicating lowest score on sitting function (highest need of support) and 8 indicating highest function on sitting function (lowest need of support)
four weeks
Secondary Box and block test (number of blocks moved in one minute) Measures of physical function at 12 Occasions, the mesures will be perfomed three times each week for four weeks.The score is the number of blocks carried from one compartment to the other in one minute. Score each hand separately.
After testing, the examiner should count the blocks If a patient transports two or more blocks at the same time, this should be noted and the number subtracted from the total.
four weeks
See also
  Status Clinical Trial Phase
Recruiting NCT05571033 - Operant Conditioning of the Soleus Stretch Reflex in Adults With Cerebral Palsy N/A
Completed NCT00011024 - Prospective Studies of the Use of Self Hypnosis, Acupuncture and Osteopathic Manipulation on Muscle Tension in Children With Spastic Cerebral Palsy Phase 2
Recruiting NCT05810779 - Dynamic Surface Exercise and Trunk Targeted Training in Children With Spastic Cerebral Palsy N/A
Completed NCT01049581 - Effects of Pediatric Aquatic Therapy in Children With Spastic Cerebral Palsy N/A
Completed NCT04634136 - Full-spectrum Medical Cannabis for Treatment of Spasticity in Patients With Severe Forms of Cerebral Palsy N/A
Recruiting NCT06070233 - Radiosurgery Treatment for Spasticity Associated With Stroke, SCI & Cerebral Palsy N/A
Completed NCT01815814 - Therapeutic Potential of Myofascial Structural Integration in Children With Cerebral Palsy N/A
Recruiting NCT05113433 - Effects of Different Time Period of Standing Frame on Spasticity and Gait in Children With Spastic Cerebral Palsy. N/A
Recruiting NCT03676439 - Lateral Cord Magnetic Stimulation For Refractory Spastic Cerebral Palsy Phase 2/Phase 3
Completed NCT03708757 - Effect of Post Isometric Relaxation Technique & Eccentric Muscle Contraction on Hamstring Spasticity in CP N/A
Not yet recruiting NCT03529682 - Circuit Training in Children With Cerebral Palsy N/A
Not yet recruiting NCT06407921 - Whole Body Vibration and BOSU Ball in Spastic Cerebral Palsy N/A
Not yet recruiting NCT06407856 - Dual Task Training in Spastic Cerebral Palsy N/A
Not yet recruiting NCT06407869 - Effects of Functional Progressive Strength Training in Children With Spastic Cerebral Palsy N/A
Active, not recruiting NCT06330311 - Effectiveness of Whole-Body Vibration N/A
Terminated NCT00955877 - Extended-release Epidural Morphine for Acute Post-operative Analgesia Following Selective Dorsal Rhizotomy in Children N/A
Completed NCT02359799 - Robotic Rehabilitation of Cerebral Palsy N/A
Not yet recruiting NCT05340439 - INcobotulinumtoxina in ChIldren Upper and Lower Limb sPasticITy (INCIPIT) Phase 2
Completed NCT01147653 - A Randomized Study of Autologous Umbilical Cord Blood Reinfusion in Children With Cerebral Palsy Phase 2
Recruiting NCT04925102 - Prediction of Recovery in Spastic Cerebral Palsy.